Table of Contents

company-logo

Formycon AG develops and markets biosimilar products. Its product pipeline includes FYB201, a biosimilar candidate for Lucentis, an ophthalmic drug used in the treatment of neovascular age-related macular degeneration and other serious eye diseases; FYB202, a biosimilar candidate for Stelara, a biopharmaceutical used in the treatment of inflammatory diseases, such as moderate to severe psoriasis, as well as for the treatment of Crohn's disease and ulcerative colitis, which is in the Phase III clinical trial; and FYB203, a biosimilar candidate for Eylea to treat neovascular age-related macular degeneration and other eye diseases that is in Phase III clinical trials. The company is also developing FYB206; and FYB207, an antiviral drug for the treatment of COVID-19. It has a collaboration agreement with Leukocare AG to develop stable formulations for various candidates in its product pipeline. The company was formerly known as Nanohale AG and changed its name to Formycon AG in 2012. Formycon AG was founded in 1999 and is headquartered in Planegg, Germany.

Formycon Dividend Announcement

• Formycon does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on Formycon dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

Formycon Dividend History

Formycon Dividend Yield

Formycon current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing Formycon stock? Use our calculator to estimate your expected dividend yield:

Formycon Financial Ratios

P/E ratio14.53
PEG ratio3.78
P/B ratio1.61
ROE11.84%
Payout ratio0.00%
Current ratio2.10
Quick ratio2.06
Cash Ratio0.89

Formycon Dividend FAQ

Does Formycon stock pay dividends?
Formycon does not currently pay dividends to its shareholders.
Has Formycon ever paid a dividend?
No, Formycon has no a history of paying dividends to its shareholders. Formycon is not known for its dividend payments.
Why doesn't Formycon pay dividends?
There are several potential reasons why Formycon would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will Formycon ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While Formycon has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is Formycon a dividend aristocrat?
Formycon is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is Formycon a dividend king?
Formycon is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is Formycon a dividend stock?
No, Formycon is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy Formycon stocks?
To buy Formycon you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy Formycon stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.